
We envision a world where radically innovative medical technologies enable people to live longer, healthier, and happier lives.

Accelerating the future of healthcare
We Unlock MedTech by finding overlooked early stage MedTech entrepreneurs with the potential to fundamentally transform healthcare and we help them drive to first revenue or first-in-human clinical validation.
We invest in companies that can radically transform healthcare, by improving efficiencies and providing access across the care continuum. We focus on innovations that optimize clinical outcomes with improved health economics by:
- Reducing the time to diagnose, treat, and/or recover from disease
- Replacing costly and complex surgeries with simple procedures
- Better managing and preventing chronic care conditions



Accelerating the future of healthcare
We Unlock MedTech by finding overlooked early stage MedTech entrepreneurs with the potential to fundamentally transform healthcare and we help them drive to first revenue or first-in-human clinical validation.
We invest in companies that can radically transform healthcare, by improving efficiencies and providing access across the care continuum. We focus on innovations that optimize clinical outcomes with improved health economics by:
- Reducing the time to diagnose, treat, and/or recover from disease
- Replacing costly and complex surgeries with simple procedures
- Better managing and preventing chronic care conditions


Team
product market fit
scalability
opportunity
Approach
Our four-point vetting framework coupled with our combined 45 years of deep domain experience across financing, building, and exiting, we equip and support innovative startups with custom playbooks and funding, ensuring they’re on the right trajectory for commercialization and exit.
Portfolio

Minimally invasive transcatheter tricuspid heart valve replacement that replaces open heart surgery
“Features has a very thorough due diligence process, with their deep understanding of the structural heart market, operational background and strategic relationships.”
Ramji Iyer, PhD
Founder & CEO, Laplace Interventional

CL Tian
Founder & CEO, Phiex Technologies

Novel minimally invasive therapeutic platform to treat multiple diseases of the uterus
Keren Leshem
Former CEO, OCON Therapeutics

Shaping the future of wireless power transfer for implantable
medical devices
Omari Bouknight
CEO, Resonant Link Medical

Minimally invasive transcatheter tricuspid heart valve replacement that replaces open heart surgery
“Features has a very thorough due diligence process, with their deep understanding of the structural heart market, operational background and strategic relationships.”
Ramji Iyer, PhD
Founder & CEO, Laplace Interventional

CL Tian
Founder & CEO, Phiex Technologies

Novel minimally invasive therapeutic platform to treat multiple diseases of the uterus
Keren Leshem
former CEO, OCON Therapeutics

Shaping the future of wireless power transfer for implantable
medical devices
Omari Bouknight
CEO, Resonant Link Medical
Expertise
Connector, Financial and Strategic Advisor, Over $4B in Transactions, Board Member, Kauffman Fellow
Inventor, Researcher, and Award Winning Product Developer. Worked with 100+ companies, 16 patents, 23+ peer reviewed publications